Search clinical trials for: MEDI6469 Plus Durvalumab
Total 5463 results
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
Providence Health & ServicesMedImmune LLC; Providence Cancer Center, Earle A. Chiles Research Institute; Robert...CompletedMetastatic Breast Cancer | Lung Metastases | Liver MetastasesUnited States
-
Tae Won KimTerminatedColorectal Cancer | Solid TumorKorea, Republic of
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseChina
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
Providence Health & ServicesMedImmune LLCTerminatedColorectal NeoplasmsUnited States
-
Weill Medical College of Cornell UniversityAstraZenecaCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
Tata Memorial CentreRecruiting
-
Zhejiang UniversityNot yet recruitingHepatocellular CarcinomaChina
-
Henan Cancer HospitalRecruitingAlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerSCLC, Extensive StageChina
-
Providence Health & ServicesMedImmune LLCCompleted
-
AstraZenecaActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Austria, Israel, Australia
-
AstraZenecaKappa SantéRecruiting
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Yonsei UniversityCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
Hark Kyun KimRecruiting
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
AstraZenecaCompleted
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingHepatocellular CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
ETOP IBCSG Partners FoundationAstraZeneca AG SwitzerlandNot yet recruiting
-
AstraZenecaActive, not recruiting
-
Institut Claudius RegaudActive, not recruiting
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
University Medical Center GroningenCambridge University Hospitals NHS Foundation TrustRecruitingEsophageal CancerNetherlands
-
Asan Medical CenterSamsung Medical CenterActive, not recruitingCholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder CancerKorea, Republic of
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Seoul National University... and other collaboratorsNot yet recruiting
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
Peregrine PharmaceuticalsWithdrawn
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
MedPacto, Inc.AstraZenecaNot yet recruitingUrothelial Carcinoma Recurrent | Advanced Urothelial CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Australia